Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis

Published:2012-11-22 Issue:1 Volume:108 Page:39-48
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Lee J,Hahn S,Kim D-W,Kim J,Kang S N,Rha S Y,Lee K B,Kang J-H,Park B-J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2012516.pdf

Reference52 articles.

1. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12 (6): 1272–1280

2. Adenis A, Ferte C, Penel N (2010) Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis. Invest New Drugs 28 (2): 178–184

3. Assersohn L, Norman AR, Cunningham D, Iveson T, Seymour M, Hickish T, Massey A, Prior Y, Hill ME (2003) A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary. Eur J Cancer 39 (8): 1121–1128

4. Balana C, Manzano JL, Moreno I, Cirauqui B, Abad A, Font A, Mate JL, Rosell R (2003) A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site. Ann Oncol 14 (9): 1425–1429

5. Briasoulis E, Fountzilas G, Bamias A, Dimopoulos MA, Xiros N, Aravantinos G, Samantas E, Kalofonos H, Makatsoris T, Mylonakis N, Papakostas P, Skarlos D, Varthalitis I, Pavlidis N (2008) Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study. Cancer Chemother Pharmacol 62 (2): 277–284

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study;ESMO Open;2024-08

2. Karzinom unklaren Ursprungs – interdisziplinäre Therapiestruktur;Die Onkologie;2024-02-21

3. Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary;Journal of the National Comprehensive Cancer Network;2024-01

4. CUP-Syndrom;Therapie-Handbuch - Onkologie und Hämatologie;2024

5. Pelvic metastatic squamous cell carcinoma of unknown primary site: A case report and brief literature review;Medicine;2023-12-29